Investigational interstitial lung disease (ILD) drug, efzofitimod, shows early signs of efficacy in patients with pulmonary ...

Agilus Diagnostics, in collaboration with Sebia, introduces an innovative Anti-MCV antibody test that enhances early ...

Agilus Diagnostics launches new Anti-MCV antibody test that provides early RA diagnosis, improves patient outcomes: Our Bureau, Bengaluru Tuesday, July 15, 2025, 12:15 Hrs [IST] A ...

The anti-MCV test enables early identification of rheumatoid arthritis in patients who test negative for standard markers ...